Metraipolis › archive › dc_c6eecc19fe31

POLB 001, a p38 MAPK inhibitor, decreases local and systemic inflammatory responses following in vivo LPS administration in healthy volunteers: a randomised,… — Europe PMC PMID:41660627

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41660627
DOI
10.3389/fimmu.2025.1684307
License (as archived)
solo-consultazione
Archived
2026-11-06T13:29:20.857Z
SHA-256 of the archived text
e2532a89c8135072eaca2016ac47433f66b2d11bfa1139f161ef2c614c31aa69
Stable URL of this page
https://metraipolis.com/documento/dc_c6eecc19fe31

How to cite

POLB 001, a p38 MAPK inhibitor, decreases local and systemic inflammatory responses following in vivo LPS administration in healthy volunteers: a randomised,… — Europe PMC PMID:41660627 — Europe PMC (en), https://europepmc.org/article/MED/41660627 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c6eecc19fe31 (Metraipolis archive dc_c6eecc19fe31, sha256 e2532a89c8135072eaca2016ac47433f66b2d11bfa1139f161ef2c614c31aa69)
BibTeX
@misc{dcc6eecc19fe31,
  title = {POLB 001, a p38 MAPK inhibitor, decreases local and systemic inflammatory responses following in vivo LPS administration in healthy volunteers: a randomised,… — Europe PMC PMID:41660627},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41660627},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c6eecc19fe31; sha256 e2532a89c8135072eaca2016ac47433f66b2d11bfa1139f161ef2c614c31aa69},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41660627. Agents can read the archived copy with the MCP tool read_document.